Companies

Sana Biotechnology, Inc. (SANA) SEC filings

CIK 0001770121 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Net income (USD)-244.2 M-269.5 M
Diluted EPS (USD/shares)-0.96-1.43

Latest filings

FiledFormDescriptionPeriod
2026-10-064PRIMARY DOCUMENT2026-10-05
2026-09-088-K8-K items 7.01,9.012026-09-08
2026-08-274PRIMARY DOCUMENT2026-08-26
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-1010-Q10-Q2026-06-30
2026-08-108-K8-K items 2.02,9.012026-08-10
2026-07-074PRIMARY DOCUMENT2026-07-06
2026-06-054PRIMARY DOCUMENT2026-06-04
2026-06-054PRIMARY DOCUMENT2026-06-04
2026-06-054PRIMARY DOCUMENT2026-06-04
2026-06-054PRIMARY DOCUMENT2026-06-04
2026-06-054PRIMARY DOCUMENT2026-06-04
2026-06-054PRIMARY DOCUMENT2026-06-04
2026-06-054PRIMARY DOCUMENT2026-06-04
2026-06-054PRIMARY DOCUMENT2026-06-04
2026-06-058-K8-K items 5.072026-06-04
2026-05-21SCHEDULE 13GSCHEDULE 13G
2026-05-158-K8-K items 8.012026-05-15
2026-05-11S-8S-8
2026-05-1110-Q10-Q2026-03-31
2026-05-118-K8-K items 2.02,9.012026-05-11
2026-04-24ARSARS2025-12-31
2026-04-24DEFA14ADEFA14A
2026-04-24DEF 14ADEF 14A2026-06-04
2026-04-248-K8-K items 5.022026-04-22

Forms on file (last 1,000): 4 146, 8-K 67, 3 26, 4/A 19, 10-Q 17, SC 13G/A 15, 144 13, SC 13G 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=SANA (0.002 USD), /gw/filings/filings?ticker=SANA&form=8-K, /gw/filings/facts?ticker=SANA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange